A high‐throughput bioanalytical platform using automated infusion for tandem mass spectrometric method optimization and its application in a metabolic stability screen
- 27 April 2009
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 23 (11), 1579-1591
- https://doi.org/10.1002/rcm.4037
Abstract
Liquid chromatography/tandem mass spectrometry (LC/MS/MS) is the bioanalytical method of choice to support plate‐based, in vitro early ADME (Absorption, Distribution, Metabolism and Excretion) screens such as metabolic stability (Metstab) assessment. MS/MS method optimization has historically been the bottleneck in this environment, where samples from thousands of discrete compounds are analyzed on a monthly basis, mainly due to the lack of a high‐quality commercially available platform to handle the necessary MS/MS method optimization steps for sample analysis by selected reaction monitoring (SRM) on triple quadrupole mass spectrometers. To address this challenge, we recently developed a highly automated bioanalytical platform by successfully integrating QuickQuan™ 2.0, a unique high‐throughput solution featuring MS/MS method optimization by automated infusion, with a customized in‐house software tool in support of a Metstab screen. In this platform, a dual‐column setup running parallel chromatography was also implemented to reduce the bioanalytical cycle time for LC/MS/MS sample analysis. A set of 45 validation compounds was used to demonstrate the speed, quality and reproducibility of MS/MS method optimization, sample analysis, and data processing using this automated platform. Metstab results for the validation compounds in microsomes from multiple species (human, rat, mouse) showed good consistency within each batch, and also between batches conducted on different days. We have achieved and maintained a monthly throughput of 1300 compound assays representing 500 discrete compounds per instrument per month on this platform, and it has been used to generate metabolic stability data for more than 25 000 compounds to date with an overall success rate of more than 95%. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 21 references indexed in Scilit:
- Application of ion trap technology to liquid chromatography/mass spectrometry quantitation of large peptidesRapid Communications in Mass Spectrometry, 2008
- Comparison of MALDI to ESI on a Triple Quadrupole Platform for Pharmacokinetic AnalysesAnalytical Chemistry, 2007
- A generic fast solid‐phase extraction high‐performance liquid chromatography/mass spectrometry method for high‐throughput drug discoveryRapid Communications in Mass Spectrometry, 2007
- High-Throughput Mass Spectrometry Screening for Inhibitors of Phosphatidylserine DecarboxylaseSLAS Discovery, 2007
- High-Throughput Cytochrome P450 Inhibition Assays Using Laser Diode Thermal Desorption-Atmospheric Pressure Chemical Ionization-Tandem Mass SpectrometryAnalytical Chemistry, 2007
- Quantitative liquid chromatography/time‐of‐flight mass spectrometryBiomedical Chromatography, 2007
- Ultra‐performance liquid chromatography coupled to time‐of‐flight mass spectrometry for robust, high‐throughput quantitative analysis of an automated metabolic stability assay, with simultaneous determination of metabolic dataRapid Communications in Mass Spectrometry, 2006
- Automatable Formats of Higher Throughput ADMET Profiling for Drug Discovery SupportSLAS Technology, 2005
- Validation of a high‐throughput absorption, distribution, metabolism, and excretion (ADME) system and results for 60 literature compoundsRapid Communications in Mass Spectrometry, 2005
- Higher‐throughput screening for Caco‐2 permeability utilizing a multiple sprayer liquid chromatography/tandem mass spectrometry systemRapid Communications in Mass Spectrometry, 2003